Eli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This once-weekly injection targets multiple hormone receptors. The drug also improved heart health markers. Experts believe retatrutide could be a game-changer for treating obesity and improving patient health.